Clinical Trial Update: Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on infliximab for immune checkpoint inhibitor–induced colitis; the study in melanoma patients is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Melanoma

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Melanoma Stage III, Melanoma Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING